MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer

by Packman Kathryn, Xia Mingxuan, Kolinsky Kenneth, Higgins Brian, Tovar Christian, Heimbrook David C, Vassilev Lyubomir T
Published 2011-05-01

MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines

by Lothe Ragnhild A, Berg Marianne, Noordhuis Paul, Paulsen Erik B, Ohnstad Hege O, Vassilev Lyubomir T, Myklebost Ola
Published 2011-05-01